Biocardia to host q1 2025 corporate update and financial results conference call on may 14, 2025

Sunnyvale, calif., may 09, 2025 (globe newswire) -- biocardia®, inc. [nasdaq:bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the three months ended march 31, 2025 by conference call on wednesday, may 14, 2025 at 4:30 pm edt. following management's formal remarks, there will be a question-and-answer session.
BCDA Ratings Summary
BCDA Quant Ranking